{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:34:13Z","timestamp":1786736053557,"version":"build-2736575974"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Family Med Prim Care"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jfmpc.jfmpc_876_19","type":"journal-article","created":{"date-parts":[[2020,3,22]],"date-time":"2020-03-22T04:30:08Z","timestamp":1584851408000},"page":"1287","source":"Crossref","is-referenced-by-count":21,"title":["A review on management of gestational trophoblastic neoplasia"],"prefix":"10.4103","volume":"9","author":[{"given":"Elham","family":"Saffarieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeyedehYousefi Reyhaneh","family":"Sharami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2249-4863.281214-1","first-page":"F1000 Faculty Rev","article-title":"Understanding and management of gestational trophoblastic disease.Version 1","author":"Ning","year":"1000","journal-title":"F"},{"key":"key-10.4103\/2249-4863.281214-2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2012.11.010","article-title":"Placental site and epithelioid trophoblastic tumours: diagnostic pitfalls","author":"Moutte","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-3","unstructured":"Bruce S, Sorosky J. Gestational Trophoblastic Disease. Stat Pearls Publishing; 2017."},{"key":"key-10.4103\/2249-4863.281214-4","first-page":"71729","article-title":"Gestational trophoblastic disease","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"key-10.4103\/2249-4863.281214-5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5306\/wjco.v10.i2.28","article-title":"Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide","author":"Braga","year":"2019","journal-title":"World J Clin Oncol"},{"key":"key-10.4103\/2249-4863.281214-6","doi-asserted-by":"crossref","first-page":"A1193","DOI":"10.1136\/bmj.a1193","article-title":"Gestational trophoblastic disease: Current management of hydatidiform mole","author":"Sebire","year":"2008","journal-title":"BMJ"},{"key":"key-10.4103\/2249-4863.281214-7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.2012.43.1817","article-title":"EMA\/CO for high-risk gestational trophoblastic neoplasia: Good outcomes with induction low-dose etoposide-cisplatin and genetic analysis","author":"Alifrangis","year":"2013","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2249-4863.281214-8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/15513810903266120","article-title":"Current issues in the histopathology of gestational trophoblastic tumors","author":"Sebire","year":"2010","journal-title":"Fetal Pediatr Pathol"},{"key":"key-10.4103\/2249-4863.281214-9","first-page":"285","article-title":"Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors","author":"Harvey","year":"2010","journal-title":"J Reprod Med"},{"key":"key-10.4103\/2249-4863.281214-10","first-page":"65","article-title":"Gestational trophoblastic tumors: A timely review of diagnostic pathology","author":"Pei","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.4103\/2249-4863.281214-11","doi-asserted-by":"crossref","first-page":"e6490","DOI":"10.7717\/peerj.6490","article-title":"Incidence of gestational trophoblastic disease in South Korea: A longitudinal, population-based study","author":"Yuk","year":"2019","journal-title":"Peer J"},{"key":"key-10.4103\/2249-4863.281214-12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: Epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","author":"Lurain","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/2249-4863.281214-13","first-page":"15","article-title":"Inter-observer variability in the histologic criteria of diagnosis of hydatidiform moles","author":"Sarmadi","year":"2019","journal-title":"Malays J Pathol"},{"key":"key-10.4103\/2249-4863.281214-14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1148\/rg.2017160140","article-title":"Gestational trophoblastic disease: Clinical and imaging features","author":"Shaaban","year":"2017","journal-title":"Radiographics"},{"key":"key-10.4103\/2249-4863.281214-15","doi-asserted-by":"crossref","unstructured":"Lurain JR. Gestational trophoblastic disease. I. Epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 2010;203:531-9.","DOI":"10.1016\/j.ajog.2010.06.073"},{"key":"key-10.4103\/2249-4863.281214-16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13669-013-0070-7","article-title":"Clinical epidemiology of gestational trophoblastic disease","author":"Strohl","year":"2014","journal-title":"Curr Obstet Gynecol Rep"},{"key":"key-10.4103\/2249-4863.281214-17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/01443615.2013.771159","article-title":"The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome","author":"Savage","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"key-10.4103\/2249-4863.281214-18","first-page":"200","article-title":"Gestational trophoblastic disease at Sultan Qaboos University Hospital: Prevalence, risk factors, histological features, sonographic findings, and outcomes","author":"Al","year":"2019","journal-title":"Oman Med J"},{"key":"key-10.4103\/2249-4863.281214-19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2017.12.007","article-title":"Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?","author":"Braga","year":"2018","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-20","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMcp0900696","article-title":"Molar pregnancy","author":"Berkowitz","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2249-4863.281214-21","first-page":"1267","article-title":"Invasive mole of the uterus: A description of twocases managed by hysterectomy","author":"Ahmed","year":"2015","journal-title":"Egyptian J Radiol Nuclear Med"},{"key":"key-10.4103\/2249-4863.281214-22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/PAS.0000000000000937","article-title":"Choriocarcinoma in women: Analysis of a case series with genotyping","author":"Savage","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/2249-4863.281214-23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/IJPM.IJPM_45_18","article-title":"A malignant placental site trophoblastic tumor of the uterus with multiple metastases: A case report of a rare tumor showing an aggressive behavior","author":"Fathaddin","year":"2019","journal-title":"Indian J Pathol Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0377-4929","issn-type":"print"},{"key":"key-10.4103\/2249-4863.281214-24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ygyno.2019.03.011","article-title":"Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy","author":"Gadducci","year":"2019","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2016.10.024","article-title":"Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities?","author":"Horowitz","year":"2017","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15513810903266138","article-title":"Histopathological diagnosis of hydatidiform mole: Contemporary features and clinical implications?","author":"Sebire","year":"2010","journal-title":"Fetal Pediatr Pathol"},{"key":"key-10.4103\/2249-4863.281214-27","doi-asserted-by":"crossref","unstructured":"Haneen AM, Daniyah S, Abdelrazak M. Gestational trophoblastic disease presents as an ectopic tubal pregnancy, a rare entity. Hindawi, Case Rep Obstet Gynecol 2019;2019:3. Article ID 7153170.","DOI":"10.1155\/2019\/7153170"},{"key":"key-10.4103\/2249-4863.281214-28","first-page":"ED10","article-title":"Molar pregnancy presents as tubal ectopic pregnancy: A rare case report","author":"Beena","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"key-10.4103\/2249-4863.281214-29","doi-asserted-by":"crossref","first-page":"vi39","DOI":"10.1093\/annonc\/mdt345","article-title":"Gestational trophoblastic disease: ESMO clinical practice guidelines","author":"Seckl","year":"2013","journal-title":"Ann Oncol"},{"key":"key-10.4103\/2249-4863.281214-30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1742271X17748514","article-title":"Ultrasound diagnosis of molar pregnancy","author":"Ross","year":"2018","journal-title":"Ultrasound"},{"key":"key-10.4103\/2249-4863.281214-31","doi-asserted-by":"crossref","first-page":"e11312","DOI":"10.1097\/MD.0000000000011312","article-title":"Partial molar pregnancy in the cesarean scar: A case report and literature review","author":"Ling","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/2249-4863.281214-32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1109\/RBME.2009.2034865","article-title":"Histopathological image analysis: A review","author":"Gurcan","year":"2009","journal-title":"IEEE Rev Biomed Eng"},{"key":"key-10.4103\/2249-4863.281214-33","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.12659\/MSM.911012","article-title":"Histopathological analysis of 173 consecutive patients with colorectal carcinoma: A pathologist's view","author":"G\u00f6ret","year":"2018","journal-title":"Med Sci Monit"},{"key":"key-10.4103\/2249-4863.281214-34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1470-2045(07)70204-8","article-title":"Gestational trophoblastic neoplasia--pathogenesis and potential therapeutic targets","author":"Shih","year":"2007","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/2249-4863.281214-35","first-page":"445","article-title":"Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia.A progress report","author":"Kohorn","year":"2002","journal-title":"J Reprod Med"},{"key":"key-10.4103\/2249-4863.281214-36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"key-10.4103\/2249-4863.281214-37","first-page":"181","article-title":"Management of gestational trophoblastic neoplasia","author":"Neil","year":"2009","journal-title":"Seminars Oncol"},{"key":"key-10.4103\/2249-4863.281214-38","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ygyno.2008.09.005","article-title":"Current management of gestational trophoblastic disease","author":"Berkowitz","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-39","doi-asserted-by":"crossref","unstructured":"Andressa B, Ant\u00f4nio B, Ross SB. Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet 2015;37:42-51. Rio de Janeiro Jan.","DOI":"10.1590\/SO100-720320140005198"},{"key":"key-10.4103\/2249-4863.281214-40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1590\/SO100-720320140005198","article-title":"Diagnosis, classification and treatment of gestational trophoblastic neoplasia","author":"Biscaro","year":"2015","journal-title":"Rev Bras Ginecol Obstet"},{"key":"key-10.4103\/2249-4863.281214-41","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdx211","article-title":"Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified.A new retrospective analysis from a nationwide dataset?","author":"Eysbouts","year":"2017","journal-title":"Ann Oncol"},{"key":"key-10.4103\/2249-4863.281214-42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ygyno.2018.04.001","article-title":"Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients","author":"Jiang","year":"2018","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-43","doi-asserted-by":"crossref","unstructured":"Lawrence HL, Lisandra SB, Eliane AH, Fushida K, Francisco RP. Is Doppler ultrasound useful for evaluating gestational trophoblastic disease? Clinics 2015;70:810-5. S\u00e3o Paulo Dec.","DOI":"10.6061\/clinics\/2015(12)08"},{"key":"key-10.4103\/2249-4863.281214-44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/j.sult.2019.03.002","article-title":"Imaging in gestational trophoblastic disease","author":"Lin","year":"2019","journal-title":"Semin Ultrasound CT MR"},{"key":"key-10.4103\/2249-4863.281214-45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AOG.0000000000001554","article-title":"Second curettage for low-risk nonmetastatic gestational trophoblastic neoplasia","author":"Osborne","year":"2016","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/2249-4863.281214-46","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/1471-0528.12196","article-title":"Uterine artery pulsatility index improves prediction of methotrexate resistance in women with gestational trophoblastic neoplasia with FIGO score 5-6","author":"Sita-Lumsden","year":"2013","journal-title":"BJOG"},{"key":"key-10.4103\/2249-4863.281214-47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: A brief review","author":"Mansoori","year":"2017","journal-title":"Adv Pharm Bull"},{"key":"key-10.4103\/2249-4863.281214-48","doi-asserted-by":"crossref","unstructured":"Eiriksson L, Wells T, Steed H, Schepansky A, Capstick V, Hoskins P. Combined methotrexate-dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia. Gynecol Oncol 2012;124:553-7.","DOI":"10.1016\/j.ygyno.2011.10.036"},{"key":"key-10.4103\/2249-4863.281214-49","first-page":"CD007102","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","author":"Alazzam","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/2249-4863.281214-50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2007.09.006","article-title":"Treatment for low-risk gestational trophoblastic disease: Comparison of single-agent methotrexate, dactinomycin and combination regimens","author":"Abrao","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-51","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/cncr.22118","article-title":"Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia","author":"Covens","year":"2006","journal-title":"Cancer"},{"key":"key-10.4103\/2249-4863.281214-52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JCO.2010.30.4386","article-title":"2011.Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: A gynecologic oncology group study","author":"Osborne","year":"2011","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2249-4863.281214-53","first-page":"486","article-title":"Gestational trophoblastic neoplasia management: An update","author":"Sarah","year":"2007","journal-title":"Cur Opin Oncol"},{"key":"key-10.4103\/2249-4863.281214-54","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ejca.2012.09.015","article-title":"Comparing cisplatin-based combination chemotherapy with EMA\/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia","author":"Lybol","year":"2013","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/2249-4863.281214-55","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.bjc.6603608","article-title":"A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia","author":"Powles","year":"2007","journal-title":"Br J Cancer"},{"key":"key-10.4103\/2249-4863.281214-56","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bjc.6604849","article-title":"External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease","author":"Kerkmeijer","year":"2009","journal-title":"Br J Cancer"},{"key":"key-10.4103\/2249-4863.281214-57","first-page":"219","article-title":"Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia","author":"Lurain","year":"2012","journal-title":"J Reprod Med"},{"key":"key-10.4103\/2249-4863.281214-58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ygyno.2006.03.015","article-title":"The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment","author":"Yang","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gore.2019.06.002","article-title":"Leptomeningeal spread of gestational trophoblastic neoplasia in a 19-year old woman","author":"Gwacham","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"key-10.4103\/2249-4863.281214-60","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/IGC.0b013e31824d834d","article-title":"Vergote EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia","author":"Han","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"key-10.4103\/2249-4863.281214-61","first-page":"36","article-title":"Outcome of treatment with EMA\/EP (etoposide methotrexate and actinomycin-D\/etoposide and cisplatin) regimen in gestational trophoblastic neoplasia","author":"Aminimoghaddam","year":"2018","journal-title":"Med J Islam Repub Iran"},{"key":"key-10.4103\/2249-4863.281214-62","first-page":"214","article-title":"Evaluation of the relation between treatment results and predictive factors in metastatic and high risk gestational trophoblastic neoplasia","author":"Hasanzadeh","year":"2019","journal-title":"Middle East J Cancer"},{"key":"key-10.4103\/2249-4863.281214-63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejca.2018.12.033","article-title":"The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia","author":"Frijstein","year":"2019","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/2249-4863.281214-64","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.mce.2006.09.003","article-title":"Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG","author":"Mitchell","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"key-10.4103\/2249-4863.281214-65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/bjp.2008.102","article-title":"Gonadotropins in doping: Pharmacological basis and detection of illicit use","author":"Stenman","year":"2008","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/2249-4863.281214-66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2007.01.053","article-title":"Management and outcome of healthy women with a persistently elevated beta-hCG","author":"Palmieri","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/2249-4863.281214-67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s13669-013-0071-6","article-title":"Management of chemoresistant and quiescent gestational trophoblastic disease","author":"Ngu","year":"2014","journal-title":"Curr Obstet Gynecol Rep"},{"key":"key-10.4103\/2249-4863.281214-68","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/bjc.2013.123","article-title":"Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements","author":"You","year":"2013","journal-title":"Br J Cancer"},{"key":"key-10.4103\/2249-4863.281214-69","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ejca.2015.05.026","article-title":"Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases","author":"Bolze","year":"2015","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/2249-4863.281214-70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1590\/0100-69912017001009","article-title":"The role of surgery in the management of women with gestational trophoblastic disease","author":"Lima","year":"2017","journal-title":"Rev Col Bras Cir"},{"key":"key-10.4103\/2249-4863.281214-71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15171\/jcs.2019.014","article-title":"Infertile couples' needs after unsuccessful fertility treatment: A qualitative study","author":"Ebrahimzadeh","year":"2019","journal-title":"J Caring Sci"},{"key":"key-10.4103\/2249-4863.281214-72","first-page":"346","article-title":"Nutrition and female fertility: An interdependent correlation","author":"Erica","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key-10.4103\/2249-4863.281214-73","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/sj.bjc.6605529","article-title":"The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l-1","author":"McGrath","year":"2010","journal-title":"Br J Cancer"},{"key":"key-10.4103\/2249-4863.281214-74","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1016\/j.ejca.2013.06.004","article-title":"The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid","author":"Taylor","year":"2013","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/2249-4863.281214-75","first-page":"321","article-title":"Quality of life of gestational neoplasia survivors: A study of patients at the Philippine General Hospital trophoblastic disease section","author":"Cagayan","year":"2010","journal-title":"J Reprod Med"},{"key":"key-10.4103\/2249-4863.281214-76","first-page":"10871","article-title":"Quality of life in gestational trophoblastic neoplasia patients after treatment in Thailand","author":"Pattaramon","year":"2014","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:36:41Z","timestamp":1786732601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/jfmpc\/Fulltext\/2020\/09030\/A_review_on_management_of_gestational.3.aspx"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["281214"],"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_876_19","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}